FindTrial
Sign In

A DOUBLE BLIND, RANDOMIZED, STRATIFIED STUDY IN PARALLEL GROUPS TO EVALUATE THE INCIDENCE OF ULCERA, BLEEDING OR PERFORATIONS DURING CHRONIC TREATMENT WITH MI-0966 OR NAPROXENE IN PATIENTS WITH REUMATOID ARTHRITIS, INTERNATIONAL COHORT

A DOUBLE BLIND, RANDOMIZED, STRATIFIED STUDY IN PARALLEL GROUPS TO EVALUATE THE INCIDENCE OF ULCERA, BLEEDING OR PERFORATIONS DURING CHRONIC TREATMENT WITH MI-0966 OR NAPROXENE IN PATIENTS WITH REUMATOID ARTHRITIS, INTERNATIONAL COHORT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REPEC
Registry ID
PER-053-99
Enrollment
550
Registered
1999-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

NA Type of group

Sponsors

MERCK SHARP & DOHME PERÚ S.R.L.,
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: NA

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
Outcome name:NA Measure:NA Timepoints:NA—

Secondary

MeasureTime frame
Outcome name:NA Measure:NA Timepoints:NA—

Contacts

Public ContactStela López

MERCK SHARP & DOHME PERÚ S.R.L

stela_lopez@merck.com4115935

Outcome results

None listed

Source: REPEC (via WHO ICTRP)